nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Completion Filing of a Second Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA)

Innovative Soft Tissue Repair Implant Possesses a Unique Nanometer-level Surface Texture BILLERICA, Mass., April 6, 2021 -- (Healthcare Sales & Marketing Network) -- nanoMesh LLC, a subsidiary of Exogenesis Corporation, announced today that it has suc... Devices, Surgery, FDA Exogenesis, nanoMesh, hernia repair

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2046771

Source: HSMN NewsFeed - April 6, 2021 Category: Pharmaceuticals Source Type: news